FDA Citizen Petition #1: DMF Carcinogen in Valsartan
On June 13, 2019, Valisure announced the detections of N, N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and the International Association for Research of Cancer (“IARC”).
Complete Valisure Citizen Petition Documents: Full Petition
Media Highlights:
- Becker’s Hospital Review: 4th carcinogen detected in common heart drug
- Bloomberg: Fourth Carcinogen Discovered in Heart Pills Used by Millions
- CBS News: Another cancer-causing chemical found in widely used blood-pressure pills
- CNBC: Pharmacy warns FDA of cancer-causing chemical found in widely used heart pill
- Fortune: Another Controversial Chemical Found in Popular Blood Pressure Medication
- Fierce Pharma: Pharmacy takes FDA to task in citizen petition over tainted valsartan
- The People’s Pharmacy: A New Carcinogen DMF Discovered in Valsartan BP Pills
- Physicians Weekly: Online pharmacy flags possible new impurity in blood pressure drug
- Reuters: Online pharmacy flags possible new impurity in blood pressure drug
